SCHEMBL19089038

SCHEMBL19089038

COc1cc(NC(=O)CCN2CCC(OC(=O)Nc3ccsc3-c3cccc(Cl)c3)CC2)c(Cl)cc1CN

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CHRM3 P20309 11/20 0.48
ADRB2 P07550 6/20 0.48
CHRM2 P08172 3/20 0.48
KDM4E B2RXH2 1/20 0.40
USP2 O75604 1/20 0.40
LMNA P02545 1/20 0.40
MAPT P10636 1/20 0.40
HPGD P15428 1/20 0.40
MAPK1 P28482 1/20 0.40
HSD17B10 Q99714 1/20 0.40
CACNA1G O43497 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
NPSR1 Q6W5P4 2/20 0.40
CHRM1 P11229 2/20 0.39
ALDH1A1 P00352 2/20 0.39
POLB P06746 1/20 0.39
THRB P10828 1/20 0.39
TSHR P16473 1/20 0.39
KMT2A Q03164 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19088800 0.89 CHRM3 (0.45) CHRM3ADRB2CHRM2KDM4EUSP2
SCHEMBL19088805 0.88 CHRM3 (0.49) CHRM3ADRB2CHRM2L3MBTL1CHRM1
SCHEMBL19088765 0.83 CHRM3 (0.51) CHRM3ADRB2CHRM2L3MBTL1NPSR1
SCHEMBL19088796 0.82 CHRM3 (0.44) CHRM3ADRB2CHRM2KDM4EHPGD
SCHEMBL19088951 0.82 CHRM3 (0.51) CHRM3ADRB2CHRM2NPSR1THRB
SCHEMBL19088799 0.80 CHRM3 (0.45) CHRM3ADRB2CHRM2L3MBTL1NPSR1
SCHEMBL19088841 0.80 ADRB2 (0.79) CHRM3ADRB2CHRM2
SCHEMBL19088842 0.80 ADRB2 (0.79) CHRM3ADRB2CHRM2
SCHEMBL19088756 0.80 ADRB2 (0.79) CHRM3ADRB2CHRM2
SCHEMBL15960456 0.78 CHRM3 (0.65) CHRM3ADRB2CHRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017114377-A1 BENZYL HETEROCYCLIC COMPOUND DERIVATIVE AND PHARMACEUTICAL APPLICATION THEREOF 四川海思科制药有限公司 2017-07-06 WO disclosed